logo
episode-header-image
Jan 2021
15m 44s

Ex-CDC director Tom Frieden on the next ...

AXIOS
About this episode
Americans fortunate enough to receive vaccines right now, outside of clinical trials, are getting ones made by either Pfizer or Moderna. But newly released data from Novavax and Johnson & Johnson suggests that more vaccines could be on the way. Dan digs into the news and why it matters, especially as COVID-19 variants begin to spread, with Tom Frieden, forme ... Show More
Up next
Dec 2021
2021's challenges for journalism
Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Axios cofounder and CEO Jim VandeHei joins Axios Re:Cap senior producer Naomi Shavin to talk about what journalists got right a ... Show More
18m 20s
Dec 2021
The year psychedelics went mainstream
Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Alison Snyder, managing editor and author of Axios Science, joins Axios Re:Cap senior producer Naomi Shavin to discuss a major ... Show More
11m 21s
Dec 2021
Behind the scenes of How It Happened Season 3
Axios Re:Cap presents a conversation between Axios Today host Niala Boodhoo and Axios Tel Aviv reporter Barak Ravid about the third season of How It Happened: Trump's Big Deal. 
10m 56s
Recommended Episodes
Feb 2021
U.S. closer to first single-dose vaccine after Johnson & Johnson version clears major FDA hurdle; Dem divide on Biden OMB nominee, push for $15 minimum wage; Sheriff: Woods’ survival from crash “nothing short of a miracle”; First interview with Biden’s Veterans Affairs Secretary
Promising signs in pandemic: vaccine progress, cases and hospitalizations down, deaths slow in new estimate; WH: 3-4 million doses of J&J vaccine to go out next week if FDA grants emergency use; Moderna testing vaccine boosters to combat South Africa variant; WH: J&J’s production ... Show More
44m 36s
Nov 2020
Moderna's chief medical officer on its blockbuster vaccine news
Moderna Therapeutics today reported a 94.5% efficacy for its COVID-19 vaccine, which needn't be stored at the same ultra-cold temperatures as does a similar vaccine developed by Pfizer. It also said short-term safety concerns, such as headaches and injection site soreness, self-r ... Show More
17m 46s
Dec 2020
Race for the Vaccine
On the same day the COVID-19 death toll surpassed 300,000 in the United States, the first vaccines are being administered, finally giving millions of Americans hope for a better future and a return to normalcy. We explore how officials expect to deliver a safe and effective vacci ... Show More
37m 42s
Oct 2021
Can You Mix & Match Your Covid-19 Vaccine?
The FDA meets this week to discuss boosters for the Moderna and Johnson & Johnson vaccines, and the efficacy of mixing boosters from different vaccine brands. Later, President Biden speaks from the White House on the significant progress America has made in tackling Covid-19, and ... Show More
42m 7s
Nov 2020
A Vaccine Breakthrough
<p>It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.</p><p>But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine ... Show More
24m 29s
Dec 2020
FDA Authorizes First Covid-19 Vaccine
The Food and Drug Administration has authorized a vaccine by Pfizer and BioNTech that will start reaching the most at-risk Americans today. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks through the final hurdles the vaccine had to clear over the weekend. To learn more ab ... Show More
8m 34s
Dec 2020
Your vaccine questions, answered
The Covid-19 vaccine is being distributed in the United States, and you have questions. Vox’s Umair Irfan has answers. Transcript at vox.com/todayexplained. Learn more about your ad choices. Visit podcastchoices.com/adchoices 
31m 53s
Feb 2021
Why I'm Optimistic
More than 33 million Americans have received at least one dose of a Covid-19 vaccine from Pfizer/BioNtech or Moderna. Johnson & Johnson’s vaccine candidate could receive an emergency use authorization in the coming weeks. CNN Chief Medical Correspondent Dr. Sanjay Gupta is optimi ... Show More
9m 50s
Sep 2023
A New Covid Shot for a New Covid Era
<p>On Tuesday afternoon, the U.S. government recommended that almost every American begin taking a new annual vaccine for Covid, a milestone in the nation’s three-year battle against the virus.</p><p>Apoorva Mandavilli, a science and global health reporter for The New York Times, ... Show More
26m 25s